An Immunohistochemical Study of PRAME Expression in Non-hodgkin’s Lymphoma
Journal Title: International Blood Research & Reviews - Year 2014, Vol 2, Issue 6
Abstract
Aim: Preferentially expressed antigen of melanoma (PRAME) is a cancer-testis antigen with very low/no expression in normal tissues. PRAME is an important target for tumor immunotherapy. Prognostic and in some tumors predictive importance of this expression have been shown in some solid tumors. The aim of this study is to detect the prognostic and/or predictive value of PRAME expression in non-Hodgkin’s lymphomas (NHL). Study Design: Retrospective clinico-pathological study. Methodology: PRAME expression was determined by immunohistochemistry (IHC) in 62 cases with NHL. However statistical analysis was performed in 54 cases [33 with diffuse large B cell lymphoma (DLBCL) and 21 with indolent lymphoma (IL)] due to the low number of the other subtypes. Results: PRAME expression was detected in 20 of the total 62 cases (32.3%). Nine of 33 cases with DLBCL, 7 of 21 cases with IL, 4 of 6 cases with T-NHL and both of the 2 cases of mantle cell lymphoma (MCL). Clinical variables including gender, stage, age, extranodal involvement and response to chemotherapy were not different in PRAME (+) and PRAME (-) cases. However PRAME (+) cases had longer PFS and OS than the PRAME (-) cases, however, no significant difference was found between groups in total. Furthermore, lymphoma subtype data indicated that while PRAME positivity was significantly associated with longer OS in cases with IL (p=0.049) but not in DLBCL cases (p=0.881). Multivariate Cox regression analysis showed that while response to chemotherapy was an independent risk factor, PRAME and NHL subtype were found not to be significant independent risk factors associated with the OS rate. Conclusion: PRAME expression was found in one third of the cases with NHL and there was no difference in PRAME expression in indolent lymphomas and DLBCL. Although we did not find the prognostic importance of PRAME with NHL overall, lymphoma subtype data indicated that PRAME positivity was associated with OS. This may be due to the relatively low number of the cases and also lack of comparison with RT-PCR which is the most frequently used method in detection of PRAME expression.
Authors and Affiliations
Semra Paydas, Arbil Avci Acikalin, Melek Ergin, Berna Bozkurt Duman, Gulsah Seydaoglu
Keywords
Related Articles
- EP ID EP242601
- DOI 10.9734/IBRR/2014/8832
- Views 108
- Downloads 0
Serological Markers of Hepatitis B Virus Infectivity among Hepatitis B Surface Antigen Negative Blood Donors at the University College Hospital, Ibadan
Background: Transmission of HBV infection has been documented from hepatitis B surface antigen negative blood donors. Objective: To determine the prevalence of serological markers of hepatitis B virus infectivity among...
A Probe into Protective Association of Haemoglobin Genotypes with Malaria Parasitaemia among Students of a University in Western Delta, Nigeria
Aim: This work was designed to investigate any possible protective association of haemoglobin genotypes with malaria parasitaemia among students of a private University in Western Delta. Study Design: Whole blood sample...
Haematological Changes Associated With Hepatitis E Virus Seropositivity among Human and Animal Subjects in Plateau State, Nigeria
Aim: To investigate the haematological manifestations of Hepatitis E Virus (HEV) seropositivity. Study Design: Cross sectional study. We included 592 subjects in the study; (426 humans and 166 animals). Humans were cate...
Detection of Prethrombin 1 in Human Blood Plasma
Background: Prethrombin 1 is one of prothrombin derivatives which appears in the presence of thrombin in vitro. However, existence of prethrombin 1 in vivo remained questionable. The aim of present work was to detect of...
Osteoporosis in Hemophilia
Aim: The aim of this paper is to review the pathophysiology, risk factors, prevention and treatment of osteoporosis in persons with hemophilia (PWH). Study Design and Methodology: In a search of PubMed up to September 24...